Truvian Sciences Snares $105M for its Many-in-One Blood Testing Machine

With its eyes set on securing an FDA clearance for its automated bench top blood testing system, Truvian Sciences has raised more than $105 million in new financing for the final steps of its development. The series C round will also help scale up the company’s commercialization teams in preparation for launch—alongside several new appointments to its C-suite and board of directors